| Application no. and date | 01983739.2 (espacenet) (Federated) (European Patent Register), 20011119 | | Patent/reg. no. and date | DK/EP 1337271, 20041103 | | Publication date | 20030827 | | Priority no. and date | US 250069 P, 20001130 | | EP pub. no. and date |
EP 1337271 20030827 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton,
Connecticut 06340, US | | Applicant ref. no. | 120714 | | Inventor | MYLARI, Banavara Lakshman, Pfizer Global Research and Development
Eastern Point Road,
Groton, CT 06340, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K, DK | | Opponent | | | IPC Class | A61K 45/06 (2006.01) , A61P 3/10 (2006.01) | | Title | Kombination af GABA-agonister og sorbitoldehydrogenaseinhibitorer | | Int. application no. | IB2001002213 | | Int. publication no. | WO2002043762 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
